Financials
Financial year 2025
Pharmacie du Nouveau Quartier from La Louvière, company number BE0867622339, closed financial year 2025 with a result of € 70,714 after tax. For that financial year Pharmacie du Nouveau Quartier recorded a gross margin of € 186,329 and equity of € 394,585. Compared with financial year 2024, the result moved from € 133,280 to € 70,714. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 7, 2026.
€ 394,585
▲ 10% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 70,714
▼ 47% vs 2024
Profit after tax over the fiscal year.
€ 234,138
▲ 65% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 36,027 paid out
51 % of the profit went to the shareholders, mostly to NEKO PHARMA (100 % of the shares). That is where the money ends up.
People and assets in 2025
0.8
Average over the fiscal year, from the social balance sheet.
€ 59,228
▼ 7% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,020
▼ 87% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 11,677
▼ 38% vs 2024
€ 6,267 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 60,722
▼ 2% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 41,697
▼ 5% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 191,083 | € 194,011 | € 284,024 | € 186,329 | ▼ 34% |
| Profit after taxes | € 76,753 | € 70,255 | € 133,280 | € 70,714 | ▼ 47% |
| Equity | € 236,363 | € 270,618 | € 359,898 | € 394,585 | ▲ 10% |
| Total debts | € 170,502 | € 193,873 | € 146,375 | € 135,914 | ▼ 7% |
| Cash | € 151,760 | € 184,905 | € 141,761 | € 234,138 | ▲ 65% |
| Land & buildings | € 88,488 | € 84,468 | € 80,448 | € 76,428 | ▼ 5% |
| Retained profit | € 217,763 | € 252,018 | € 341,298 | € 375,985 | ▲ 10% |
| Dividend | € 29,000 | € 36,000 | € 44,000 | € 36,027 | ▼ 18% |
| Bank debt | € 45,507 | € 32,384 | € 18,980 | € 11,677 | ▼ 38% |
| Balance sheet total | € 406,865 | € 464,491 | € 506,273 | € 530,499 | ▲ 5% |
| Employees (FTE) | 0.8 | 0.8 | 0.8 | 0.8 |
Key figures of Pharmacie du Nouveau Quartier, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Pharmacie du Nouveau Quartier?
What happened at Pharmacie du Nouveau Quartier in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 70,714 (▼ 47% vs 2024). filed late Source: NBB ↗
- Start of the company according to the CBE. KBO
- New establishment in La Louvière. KBO
In short
From € 76,753 profit in 2022 to € 70,714 profit in 2025.
Paid € 134,218 in corporate taxes since 2022.
Best year ever: 2024, with € 133,280 profit.
Paid out € 145,027 in dividends to the owners in total.
A new publication or filing at Pharmacie du Nouveau Quartier? We notify you, reason included.
Follow Pharmacie du Nouveau QuartierDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of NEKO PHARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Pharmacie du Nouveau QuartierBehind Pharmacie du Nouveau Quartier is Neko Pharma. The shares are held by NEKO PHARMA (100%).
Directors
According to the 2025 annual accounts
Director · represented by Laurence VUONG
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue du Nouveau-Quartier(PAU) 12
7100 La Louvière
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0867.622.339
- VAT number
- BE 0867.622.339
- Registered office
- Rue du Nouveau-Quartier(PAU) 12, 7100 La Louvière
- Names & denominations
- Pharmacie du Nouveau Quartier
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 5 October 2004
- Peppol
- Active · Active since 18 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers
Overige detailhandel in voedingsmiddelen, neg
Detailhandel in cosmetica en toiletartikelen
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Overige detailhandel in voedings- en genotmiddelen in gespecialiseerde winkels, n.e.g.
Detailhandel in medische en orthopedische artikelen
Overige detailhandel in voedingsmiddelen in gespecialiseerde winkels, n.e.g.
+1